Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization
Technology in Cancer Research & Treatment · 2024
DOI: 10.1177/15330338241277699 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Xi-Ya Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Maternity and Child Healthcare Hospital Affiliated to Anhui Medical University, Anhui Province Maternity and…. Hauptthemen laut MEDLINE: Body Mass Index, Genetic Predisposition to Disease, Genital Neoplasms, Female. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Higher Education Institutions of Anhui Province, Research Fund Project of Anhui Medical University, Applied Medicine Research Project of Hefei Health Commission.
Abstract (Originalsprache)
Introduction
A strong association was previously established between body mass index (BMI) and female reproductive system tumors; however, the causal relationship is unclear. We conducted a Mendelian randomization (MR) study to further explore this association.
Methods
Genetic information for BMI was retrieved from a published genome-wide association study involving 339,224 participants. Genetic associations with five common female reproductive system tumors were obtained from the FinnGen, UK Biobank studies, and other large consortia.
Results
Genetic predisposition towards BMI exhibits a significant association with multiple tumors of the female reproductive system. Specifically, for every 1-unit increase in BMI log-transformed odds ratio (OR). The OR fluctuations overall for patients with breast cancer ranged from 0.661 to 0.996 (95% confidence interval [CI],0.544-1.000, P < 0.05). When stratified by estrogen receptor (ER) status, the OR for patients with ER (+) breast cancer ranged from 0.782 to 0.844 (95% CI, 0.616-0.994, P < 0.05) and that for those with ER (-) breast cancer ranged from 0.663 to 0.789 (95% CI, 0.498-0.991, P < 0.05). Additionally, ORs were as follows for cancer types: 1.577–1.908 (95% CI, 1.049-2.371, P < 0.05) for endometrial carcinoma; 1.216–1.303 (95% CI, 1.021-1.591, P < 0.05) for high-grade serous ovarian cancer; 1.217 (95% CI, 1.034-1.432, P < 0.05) for low-grade malignant serous ovarian cancer; and 1.502 (95% CI, 1.112-2.029, P < 0.05) for endometrioid ovarian carcinoma. Furthermore, our findings indicated that genetic predisposition towards BMI did not exhibit a causal association with uterine fibroids, cervical precancerous lesions, or cervical cancer itself.
Conclusion
A genetic association was established between a high BMI and high risk of developing multiple tumors of the female reproductive system and their associated subtypes. This underscores the significance of taking measures to prevent reproductive system tumors in women who have a high BMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Maternity and Child Healthcare Hospital Affiliated to Anhui Medical University, Anhui Province Maternity and Child Healthcare Hospital, Hefei, Anhui 230001, China.
- Department of Gynecology and Obstetrics, The Fifth Clinical College of Anhui Medical University, Hefei, Anhui 230032, China.
- Department of Gynecology and Obstetrics, Luan Maternity and Child Healthcare Hospital, Luan, Anhui 237001, China.
- Department of Clinical Laboratory, Anhui Province Maternity and Child Healthcare Hospital, Hefei, Anhui 230001, China.
ORCID-Profile: Shu-Guang Zhou
Förderung
- Natural Science Foundation of Higher Education Institutions of Anhui Province
- Research Fund Project of Anhui Medical University
- Applied Medicine Research Project of Hefei Health Commission
- Postgraduate Innovation Research and Practice Program of Anhui Medical University
Zitieren
APA
Jiang, X. Y., Zheng, L., Xiong, M., Wang, S. L., Jin, Q. Q., Yang, Y. T., Fang, Y. X., Hong, L., Mei, J., & Zhou, S. G. (2024). Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241277699
Vancouver
Jiang XY, Zheng L, Xiong M, Wang SL, Jin QQ, Yang YT, et al. Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241277699
BibTeX
@article{Jiang2024,
author = {Jiang, Xi-Ya and Zheng, Lan and Xiong, Min and Wang, Sen-Lin and Jin, Qin-Qin and Yang, Yin-Ting and Fang, Ya-Xing and Hong, Lin and Mei, Jie and Zhou, Shu-Guang},
title = {Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
doi = {10.1177/15330338241277699}
}
EUVIMED